医学
胸膜液
病理
胸腔积液
心包液
DNA测序
放射科
基因组测序
肺
内科学
胸腔镜检查
呼吸道疾病
胸膜炎
诊断准确性
胸膜疾病
作者
W. K. Jacky Lam,Ken K. P. Chan,Guangya Wang,Christopher K. C. Lai,Guannan Kang,Christopher Chan,Angela C. Y. Leung,Natalie H. L. Wong,Crystal S. N. Tso,K. M. Chow,Saravanan Ramakrishnan,K. T. Wong,Charlotte H. Y. Lau,Joyce K. C. Ng,Rachel L. P. Lo,W. H. Yip,Jenny C. L. Ngai,K. W. To,Irene O. L. Tse,S. H. Cheng
出处
期刊:NEJM evidence
[New England Journal of Medicine]
日期:2026-03-24
卷期号:5 (4): EVIDoa2500237-EVIDoa2500237
被引量:1
标识
DOI:10.1056/evidoa2500237
摘要
BACKGROUND: in the pleural space, resulting in low sensitivity of microbiological culture and polymerase chain reaction-based analyses on pleural fluid. The use of metagenomic next-generation sequencing for diagnosing TBP may be limited by the background noise of DNA from nontuberculous mycobacteria. METHODS: sequencing as described above and culture using McNemar's test. RESULTS: culture (P<0.001, McNemar's test). Sequencing yielded an area-under-the-curve value of 0.9996 (95% confidence interval, 0.9988-1.0000) for differentiating TBP and non-TBP. Plasma analysis by targeted sequencing with the same alignment algorithm reported an area-under-the-curve value of 0.9475 (95% confidence interval, 0.8929-1.0000). CONCLUSIONS: genomic alignment accurately diagnosed TBP and outperformed conventional diagnostic tests. (Supported by InnoHK and the Hong Kong Tuberculosis, Chest and Heart Diseases Association; ClinicalTrials.gov number, NCT05397730.).
科研通智能强力驱动
Strongly Powered by AbleSci AI